These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 6462761)
1. [In vitro comparative study of the sensitivity of Aspergillus to antifungal agents]. Guinet R; Mazoyer MA Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):654-7. PubMed ID: 6462761 [TBL] [Abstract][Full Text] [Related]
2. Susceptibility to 5-fluorocytosine, miconazole and amphotericin B of Candida albicans strains isolated from the throat of non-AIDS patients. Paniagua GL; Monroy E; Negrete E; Vaca S Rev Latinoam Microbiol; 2002; 44(2):65-8. PubMed ID: 17063773 [TBL] [Abstract][Full Text] [Related]
3. [Comparative sensitivity of yeasts to antifungal agents using a standardized micromethod]. Guinet R Pathol Biol (Paris); 1986 May; 34(5):536-9. PubMed ID: 3534739 [TBL] [Abstract][Full Text] [Related]
4. [Antifungal susceptibilities of Aspergillus spp. strains isolated from invasive aspergillosis cases]. Gürcan S; Tikveşli M; Eryildiz C; Evci C; Ener B Mikrobiyol Bul; 2010 Apr; 44(2):273-8. PubMed ID: 20549962 [TBL] [Abstract][Full Text] [Related]
5. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003. Hsueh PR; Lau YJ; Chuang YC; Wan JH; Huang WK; Shyr JM; Yan JJ; Yu KW; Wu JJ; Ko WC; Yang YC; Liu YC; Teng LJ; Liu CY; Luh KT Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726 [TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole. Kaya AD; Kiraz N Mycoses; 2007 Nov; 50(6):447-50. PubMed ID: 17944704 [TBL] [Abstract][Full Text] [Related]
7. In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study. Mallié M; Bastide JM; Blancard A; Bonnin A; Bretagne S; Cambon M; Chandenier J; Chauveau V; Couprie B; Datry A; Feuilhade M; Grillot R; Guiguen C; Lavarde V; Letscher V; Linas MD; Michel A; Morin O; Paugam A; Piens MA; Raberin H; Tissot E; Toubas D; Wade A Int J Antimicrob Agents; 2005 Apr; 25(4):321-8. PubMed ID: 15784312 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the Sensititre YeastOne colorimetric antifungal panel and Etest with the NCCLS M38-A method to determine the activity of amphotericin B and itraconazole against clinical isolates of Aspergillus spp. Martín-Mazuelos E; Pemán J; Valverde A; Chaves M; Serrano MC; Cantón E J Antimicrob Chemother; 2003 Sep; 52(3):365-70. PubMed ID: 12917236 [TBL] [Abstract][Full Text] [Related]
9. Intrinsic in vitro susceptibility of primary clinical isolates of Aspergillus fumigatus, Aspergillus terreus, Aspergillus nidulans, Candida albicans and Candida lusitaniae against amphotericin B. Singh J; Rimek D; Kappe R Mycoses; 2006 Mar; 49(2):96-103. PubMed ID: 16466441 [TBL] [Abstract][Full Text] [Related]
10. Treatment failure in invasive aspergillosis: susceptibility of deep tissue isolates following treatment with amphotericin B. Paterson PJ; Seaton S; Prentice HG; Kibbler CC J Antimicrob Chemother; 2003 Nov; 52(5):873-6. PubMed ID: 14519673 [TBL] [Abstract][Full Text] [Related]
11. In vitro susceptibility patterns of Aspergillus and Fusarium species isolated from equine ulcerative keratomycosis cases in the midwestern and southern United States with inclusion of the new antifungal agent voriconazole. Pearce JW; Giuliano EA; Moore CP Vet Ophthalmol; 2009; 12(5):318-24. PubMed ID: 19751493 [TBL] [Abstract][Full Text] [Related]
12. In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agents. Denning DW; Hanson LH; Perlman AM; Stevens DA Diagn Microbiol Infect Dis; 1992 Jan; 15(1):21-34. PubMed ID: 1309690 [TBL] [Abstract][Full Text] [Related]
13. [In vitro sensitivity of Aspergillus to terbinafine: comparative study on amphotericin B, 5-fluorocytosine and ketoconazole]. Goudard M; Regli P; Buffard Y; Gabriel B Pathol Biol (Paris); 1988 Feb; 36(2):139-43. PubMed ID: 3279381 [TBL] [Abstract][Full Text] [Related]
14. Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B. Warn PA; Morrissey G; Morrissey J; Denning DW J Antimicrob Chemother; 2003 Apr; 51(4):913-9. PubMed ID: 12654746 [TBL] [Abstract][Full Text] [Related]
15. [Assessment of the sensitivity to antifungal agents of clinical isolates of Candida albicans serotype A and B by the ATB Fungus method]. Quindós G; San Millán R; Burgos A; Lipperheide V; Tellaetxe M; Alonso R; Barturen B; Pontón J Enferm Infecc Microbiol Clin; 1995 Apr; 13(4):209-12. PubMed ID: 7779872 [TBL] [Abstract][Full Text] [Related]
16. [Determination of the in vitro antifungal susceptibility of clinically important yeasts using the Sensititre system]. Carrillo-Muñoz AJ; Quindós G; Gasser I; Tur-Tur C; Ruesga MT; Alonso-Vargas R; Arévalo P; Bornay-Llinares FJ; Santos P; del Valle O Rev Esp Quimioter; 1999 Jun; 12(2):126-35. PubMed ID: 10562673 [TBL] [Abstract][Full Text] [Related]
17. Comparison of spectrophotometric and visual readings of NCCLS method and evaluation of a colorimetric method based on reduction of a soluble tetrazolium salt, 2,3-bis [2-methoxy-4-nitro-5-[(sulfenylamino) carbonyl]-2H-tetrazolium-hydroxide], for antifungal susceptibility testing of Aspergillus species. Meletiadis J; Mouton JW; Meis JF; Bouman BA; Donnelly PJ; Verweij PE; J Clin Microbiol; 2001 Dec; 39(12):4256-63. PubMed ID: 11724829 [TBL] [Abstract][Full Text] [Related]
18. Comparative pharmacokinetics of antifungal drugs in domestic turkeys, red-tailed hawks, broad-winged hawks, and great-horned owls. Redig PT; Duke GE Avian Dis; 1985; 29(3):649-61. PubMed ID: 3907612 [TBL] [Abstract][Full Text] [Related]
19. In-vitro evaluation of antifungal agents in the treatment of yeast peritonitis complicating continuous ambulatory peritoneal dialysis (CAPD). Edwards R; Birrell LN; Finch RG Chemioterapia; 1987 Feb; 6(1):3-7. PubMed ID: 3829134 [TBL] [Abstract][Full Text] [Related]
20. Update on antifungal drug resistance mechanisms of Aspergillus fumigatus. Chamilos G; Kontoyiannis DP Drug Resist Updat; 2005 Dec; 8(6):344-58. PubMed ID: 16488654 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]